CN113693242A - Composition capable of inducing tumor cell apoptosis and preparation method and application thereof - Google Patents
Composition capable of inducing tumor cell apoptosis and preparation method and application thereof Download PDFInfo
- Publication number
- CN113693242A CN113693242A CN202111046046.3A CN202111046046A CN113693242A CN 113693242 A CN113693242 A CN 113693242A CN 202111046046 A CN202111046046 A CN 202111046046A CN 113693242 A CN113693242 A CN 113693242A
- Authority
- CN
- China
- Prior art keywords
- mass
- peptide
- composition
- rice flour
- puffed rice
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 77
- 210000004881 tumor cell Anatomy 0.000 title claims abstract description 26
- 230000006907 apoptotic process Effects 0.000 title claims abstract description 24
- 230000001939 inductive effect Effects 0.000 title claims abstract description 22
- 238000002360 preparation method Methods 0.000 title claims abstract description 12
- 108090000765 processed proteins & peptides Proteins 0.000 claims abstract description 62
- 235000007164 Oryza sativa Nutrition 0.000 claims abstract description 39
- 235000009566 rice Nutrition 0.000 claims abstract description 39
- 235000013312 flour Nutrition 0.000 claims abstract description 38
- 239000000843 powder Substances 0.000 claims abstract description 29
- 229920001491 Lentinan Polymers 0.000 claims abstract description 28
- 235000004879 dioscorea Nutrition 0.000 claims abstract description 28
- 229940115286 lentinan Drugs 0.000 claims abstract description 28
- 241000195493 Cryptophyta Species 0.000 claims abstract description 26
- 238000000034 method Methods 0.000 claims abstract description 12
- 235000002722 Dioscorea batatas Nutrition 0.000 claims abstract description 7
- 235000006536 Dioscorea esculenta Nutrition 0.000 claims abstract description 7
- 240000001811 Dioscorea oppositifolia Species 0.000 claims abstract description 7
- 235000003416 Dioscorea oppositifolia Nutrition 0.000 claims abstract description 7
- 241000209094 Oryza Species 0.000 claims description 38
- 238000002156 mixing Methods 0.000 claims description 20
- 238000001035 drying Methods 0.000 claims description 10
- 238000003756 stirring Methods 0.000 claims description 10
- 235000013305 food Nutrition 0.000 claims description 9
- DQJCDTNMLBYVAY-ZXXIYAEKSA-N (2S,5R,10R,13R)-16-{[(2R,3S,4R,5R)-3-{[(2S,3R,4R,5S,6R)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-5-(ethylamino)-6-hydroxy-2-(hydroxymethyl)oxan-4-yl]oxy}-5-(4-aminobutyl)-10-carbamoyl-2,13-dimethyl-4,7,12,15-tetraoxo-3,6,11,14-tetraazaheptadecan-1-oic acid Chemical compound NCCCC[C@H](C(=O)N[C@@H](C)C(O)=O)NC(=O)CC[C@H](C(N)=O)NC(=O)[C@@H](C)NC(=O)C(C)O[C@@H]1[C@@H](NCC)C(O)O[C@H](CO)[C@H]1O[C@H]1[C@H](NC(C)=O)[C@@H](O)[C@H](O)[C@@H](CO)O1 DQJCDTNMLBYVAY-ZXXIYAEKSA-N 0.000 claims description 7
- 102000002068 Glycopeptides Human genes 0.000 claims description 7
- 108010015899 Glycopeptides Proteins 0.000 claims description 7
- 240000000599 Lentinula edodes Species 0.000 claims description 7
- 235000001715 Lentinula edodes Nutrition 0.000 claims description 7
- 238000005303 weighing Methods 0.000 claims description 7
- 238000007664 blowing Methods 0.000 claims description 5
- 239000000463 material Substances 0.000 claims description 5
- 230000001093 anti-cancer Effects 0.000 claims description 4
- 150000003384 small molecules Chemical class 0.000 claims description 3
- 230000006882 induction of apoptosis Effects 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 9
- 230000001976 improved effect Effects 0.000 abstract description 6
- 235000016709 nutrition Nutrition 0.000 abstract description 5
- 239000002994 raw material Substances 0.000 abstract description 5
- 238000010521 absorption reaction Methods 0.000 abstract description 4
- 230000035764 nutrition Effects 0.000 abstract description 4
- 230000001737 promoting effect Effects 0.000 abstract description 3
- 240000007594 Oryza sativa Species 0.000 abstract 1
- 206010028980 Neoplasm Diseases 0.000 description 25
- 241000699670 Mus sp. Species 0.000 description 23
- 102000004169 proteins and genes Human genes 0.000 description 9
- 108090000623 proteins and genes Proteins 0.000 description 9
- 208000002720 Malnutrition Diseases 0.000 description 7
- 210000004369 blood Anatomy 0.000 description 7
- 239000008280 blood Substances 0.000 description 7
- 230000001071 malnutrition Effects 0.000 description 7
- 235000000824 malnutrition Nutrition 0.000 description 7
- 208000015380 nutritional deficiency disease Diseases 0.000 description 7
- 230000008569 process Effects 0.000 description 7
- 102000000588 Interleukin-2 Human genes 0.000 description 6
- 108010002350 Interleukin-2 Proteins 0.000 description 6
- 102000004196 processed proteins & peptides Human genes 0.000 description 6
- 230000037396 body weight Effects 0.000 description 5
- 210000002966 serum Anatomy 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- MZOFCQQQCNRIBI-VMXHOPILSA-N (3s)-4-[[(2s)-1-[[(2s)-1-[[(1s)-1-carboxy-2-hydroxyethyl]amino]-4-methyl-1-oxopentan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-3-[[2-[[(2s)-2,6-diaminohexanoyl]amino]acetyl]amino]-4-oxobutanoic acid Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@@H](N)CCCCN MZOFCQQQCNRIBI-VMXHOPILSA-N 0.000 description 4
- 206010008342 Cervix carcinoma Diseases 0.000 description 4
- 108060008682 Tumor Necrosis Factor Proteins 0.000 description 4
- 102000000852 Tumor Necrosis Factor-alpha Human genes 0.000 description 4
- 208000006105 Uterine Cervical Neoplasms Diseases 0.000 description 4
- 201000010881 cervical cancer Diseases 0.000 description 4
- 230000001965 increasing effect Effects 0.000 description 3
- 230000005764 inhibitory process Effects 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- 241000218033 Hibiscus Species 0.000 description 2
- 235000005206 Hibiscus Nutrition 0.000 description 2
- 235000007185 Hibiscus lunariifolius Nutrition 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 210000001099 axilla Anatomy 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 208000019065 cervical carcinoma Diseases 0.000 description 2
- 238000000556 factor analysis Methods 0.000 description 2
- 210000003194 forelimb Anatomy 0.000 description 2
- 230000002496 gastric effect Effects 0.000 description 2
- 238000003304 gavage Methods 0.000 description 2
- 238000011081 inoculation Methods 0.000 description 2
- 239000002504 physiological saline solution Substances 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 206010016946 Food allergy Diseases 0.000 description 1
- 108010009736 Protein Hydrolysates Proteins 0.000 description 1
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 1
- 208000010399 Wasting Syndrome Diseases 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 230000003698 anagen phase Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 210000005252 bulbus oculi Anatomy 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 229940044627 gamma-interferon Drugs 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000007365 immunoregulation Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 150000004715 keto acids Chemical class 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 210000002751 lymph Anatomy 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 235000012149 noodles Nutrition 0.000 description 1
- -1 peptide Chemical class 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- 239000003531 protein hydrolysate Substances 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 210000001541 thymus gland Anatomy 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/18—Peptides; Protein hydrolysates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L7/00—Cereal-derived products; Malt products; Preparation or treatment thereof
- A23L7/10—Cereal-derived products
- A23L7/161—Puffed cereals, e.g. popcorn or puffed rice
- A23L7/165—Preparation of puffed cereals involving preparation of meal or dough as an intermediate step
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Polymers & Plastics (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- Mycology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
The invention discloses a composition capable of inducing tumor cell apoptosis, a preparation method and application thereof, wherein the composition is prepared from the following components in percentage by mass: 10% -20% of yam small molecular peptide; 5% -10% of lentinan; 10% of algae oil powder and 60% -70% of puffed rice flour. According to the invention, by researching the proportion of the lentinan peptide and the Chinese yam micromolecule peptide, the effect of the composition on promoting tumor cell apoptosis is improved, the absorption of a human body is promoted, and the nutrition improving effect is obvious. The method optimizes the adding sequence and the loose bulk density of the raw materials, so that the loose bulk densities of the mixture I, the mixture II and the mixture III are close to each other, the prepared composition has stable quality, the appearance and the color of the product are consistent, the taste is fine and smooth, and the nutrition uniformity of the product is improved.
Description
Technical Field
The invention belongs to the field of medicines and foods, and particularly relates to a composition capable of inducing tumor cell apoptosis, a preparation method and application thereof.
Background
At present, about 40% -80% of tumor patients with malnutrition are killed directly by the malnutrition in about 20% of tumor patients.
The cause of malnutrition in patients with tumors is that tumors are a wasting disease, leading to a reduction in proteins in the body. The formula food of the composition for inducing the tumor cell apoptosis is developed, the metabolic absorption abnormality of the tumor patients is regulated, the nutritional requirements of the tumor patients are met, the incidence rate of malnutrition of the tumor patients is reduced, and the positive effect is achieved. The protein source is mainly divided into whole protein, protein hydrolysate-peptide and the like. The whole protein is decomposed into amino acids or protein hydrolysate, namely peptide, in the process of human digestion, and the protein is also partially decomposed into human harmful substances such as ammonia, keto acid, urea and the like, so that side effects are generated on human bodies. The absorption and utilization rate of the whole protein is 70 to 80 percent usually by human bodies. When a human body takes in whole protein, energy is consumed to digest and decompose the whole protein, so that the burden of a liver is increased, dyspepsia is easily caused, and the function of a kidney is influenced.
Disclosure of Invention
The invention aims to overcome the defects of the prior art and provide a composition for inducing tumor cell apoptosis.
The second purpose of the invention is to provide a preparation method of the composition for inducing tumor cell apoptosis.
The third purpose of the invention is to provide the application of the composition for inducing tumor cell apoptosis in preparing anti-cancer food.
The technical scheme of the invention is summarized as follows:
a composition for inducing tumor cell apoptosis is prepared from the following components in percentage by mass: 10% -20% of yam small molecular peptide; 5% -10% of lentinan; 10% of algae oil powder and 60% -70% of puffed rice flour.
Preferably, the composition consists of the following components in percentage by mass: 20% of yam small molecular peptide; 10% of lentinan; 10% of algae oil powder; 60 percent of puffed rice flour.
The yam small molecular peptide has a peptide mass content of more than or equal to 80 percent, and a peptide mass content of less than 1000Da relative to the molecular weight of more than or equal to 75 percent.
The lentinan peptide has a peptide mass content of more than or equal to 80 percent and a peptide mass content of more than or equal to 60 percent with a relative molecular weight of less than or equal to 500-1000 Da.
The DHA content in the algae oil powder is more than or equal to 10 percent.
The preparation method of the following composition for inducing tumor cell apoptosis comprises the following steps:
(1) weighing Chinese yam micromolecule peptide according to the mass percentage; lentinan; algae oil powder and puffed rice flour;
(2) dividing the puffed rice flour into a part A, a part B and a part C according to the mass, wherein the mass of the part A is the same as that of the yam micromolecule peptide; the mass of the part B is equal to that of the lentinan peptide, and the mass of the part C is the sum of the mass of the puffed rice flour minus the mass of the part A and the mass of the part B;
(3) airflow mixing the yam small molecular peptide and the part A of puffed rice flour for 15-25min to obtain a mixture I; airflow mixing Lentinus Edodes glycopeptide and part B of puffed rice flour for 15-25min to obtain mixture II; and (3) mixing the algae oil powder and the C part puffed rice flour for 5-15min in an air flow manner to obtain a mixture III, adding the mixture I and the mixture II into the mixture III, continuing to mix for 20-30min in an air flow manner, and drying to obtain the composition for inducing tumor cell apoptosis.
The gas flow mixing is as follows: starting the stirring paddle, wherein the speed of the stirring paddle is 6r/s, and simultaneously blowing air with the temperature of 20-30 ℃, the relative humidity of 80-90% and the air speed of 7m/s to boil the materials.
The drying comprises the following steps: air with the temperature of 60 ℃ and the relative humidity of 20-30% is introduced for 5-10 minutes at the wind speed of 10 m/s.
The application of the composition in preparing anticancer food is provided.
The invention has the advantages that:
the composition and the dosage ratio of the components are optimized, and particularly, the ratio of the lentinan peptide to the yam micromolecular peptide is researched, so that the effect of the composition on promoting tumor cell apoptosis is improved, the absorption of a human body is promoted, and the nutrition improving effect is obvious.
The method optimizes the adding sequence and the loose bulk density of the raw materials, so that the loose bulk densities of the mixture I, the mixture II and the mixture III in the step (4) are close to each other, the prepared composition has stable quality, the appearance and the color of the product are consistent, the taste is fine and smooth, and the nutrition uniformity of the product is improved.
The composition prepared by the invention has obvious effect of improving immunity for people of 10 years old and older, has no side effect, and avoids adverse consequences such as protein allergy and the like.
Detailed Description
The yam small molecule peptide is purchased from Hibiscus parviensis Biotech, Inc.
The lentinan is purchased from Hibiscus Biotech, Inc.
Algal oil powder was purchased from Qingdaoyuangkang biotechnology limited.
The puffed rice flour meets the national standard of GB 17401-2014 food safety puffed food.
The sources of the components are disclosed to enable one skilled in the art to practice the invention, but are not intended to limit the sources of the components of the invention, and other companies' corresponding products meeting the requirements may be used in the invention.
The present invention will be further illustrated by the following specific examples.
Example 1
A composition for inducing tumor cell apoptosis is prepared from the following components in percentage by mass: 20kg of Chinese yam small molecular peptide; 10kg of lentinan peptide; 10kg of algae oil powder; 60kg of puffed rice noodles.
The mass content of the yam small molecular peptides is more than or equal to 80 percent, and the mass content of the peptides with the relative molecular weight less than 1000Da is more than or equal to 75 percent.
The lentinan has a peptide mass content of 80% or more, and a peptide mass content of 60% or more with a relative molecular weight of 500-1000Da or less.
The DHA content in the algae oil powder is more than or equal to 10 percent.
Example 2
A composition for inducing tumor cell apoptosis is prepared from the following components in percentage by mass: 10kg of Chinese yam micromolecule peptide; 10kg of lentinan peptide; 10kg of algae oil powder; puffed rice flour 70 kg.
The mass content of the yam small molecular peptides is more than or equal to 80 percent, and the mass content of the peptides with the relative molecular weight less than 1000Da is more than or equal to 75 percent.
The lentinan has a peptide mass content of 80% or more, and a peptide mass content of 60% or more with a relative molecular weight of 500-1000Da or less.
The DHA content in the algae oil powder is more than or equal to 10 percent.
Example 3
A composition for inducing tumor cell apoptosis is prepared from the following components in percentage by mass: 15kg of Chinese yam micromolecule peptide; 5kg of lentinan peptide; 10kg of algae oil powder; puffed rice flour 70 kg.
The mass content of the yam small molecular peptides is more than or equal to 80 percent, and the mass content of the peptides with the relative molecular weight less than 1000Da is more than or equal to 75 percent.
The lentinan has a peptide mass content of 80% or more, and a peptide mass content of 60% or more with a relative molecular weight of 500-1000Da or less.
The DHA content in the algae oil powder is more than or equal to 10 percent.
Example 4
The preparation method of the composition for inducing the tumor cell apoptosis comprises the following steps:
(1) weighing 20Kg of yam micromolecule peptide according to the mass; 10Kg of lentinan; 10Kg of algae oil powder; 60Kg of puffed rice flour (composition of example 1);
(2) dividing the puffed rice flour into three parts A, B and C according to the mass, wherein the mass of the part A is 20Kg as that of the yam micromolecule peptide; the mass of the part B is 10Kg as that of the lentinan, and the mass of the part C is 30Kg after subtracting the sum of the mass of the part A and the mass of the part B from the mass of the puffed rice flour in the step (1);
(3) airflow mixing the yam small molecular peptide and the part A of puffed rice flour for 20min to obtain a mixture I; airflow mixing Lentinus edodes glycopeptide and part B of puffed rice flour for 20min to obtain mixture II; and (3) mixing the algae oil powder and the C part puffed rice flour for 10min in an air flow manner to obtain a mixture III, adding the mixture I and the mixture II into the mixture III, continuing to mix for 25min in an air flow manner, and drying to obtain the composition for inducing the apoptosis of the tumor cells.
And in the air flow mixing process, starting a stirring paddle, wherein the speed of the stirring paddle is 6r/s, and simultaneously blowing air with the temperature of 25 ℃, the relative humidity of 85% and the air speed of 7m/s to boil the materials.
The drying is as follows: air with the temperature of 60 ℃ and the relative humidity of 25 percent is introduced for 8 minutes at the wind speed of 10 m/s.
Example 5
The preparation method of the composition for inducing the tumor cell apoptosis comprises the following steps:
(1) weighing 10Kg of yam micromolecule peptide according to the mass; 10Kg of lentinan; 10Kg of algae oil powder; puffed rice flour 70Kg (composition of example 2);
(2) dividing the puffed rice flour into three parts A, B and C according to the mass, wherein the mass of the part A is 10Kg as that of the yam micromolecule peptide; the mass of the part B is 10Kg as that of the lentinan, and the mass of the part C is 50Kg after subtracting the sum of the mass of the part A and the mass of the part B from the mass of the puffed rice flour in the step (1);
(3) airflow mixing the yam small molecular peptide and the part A of puffed rice flour for 15min to obtain a mixture I; airflow mixing Lentinus edodes glycopeptide and part B of puffed rice flour for 15min to obtain mixture II; and (3) mixing the algae oil powder and the C part puffed rice flour for 5min in an air flow manner to obtain a mixture III, adding the mixture I and the mixture II into the mixture III, continuing to mix for 20min in an air flow manner, and drying to obtain the composition for inducing tumor cell apoptosis.
And in the air flow mixing process, starting a stirring paddle, blowing air with the temperature of 20 ℃, the relative humidity of 80% and the air speed of 7m/s into the stirring paddle at the speed of 6r/s so as to boil the materials.
The drying is as follows: air with the temperature of 60 ℃ and the relative humidity of 20 percent is introduced for 5 minutes at the wind speed of 10 m/s.
Example 6
The preparation method of the composition for inducing the tumor cell apoptosis comprises the following steps:
(1) weighing 15Kg of yam micromolecule peptide; 5Kg of lentinan; 10Kg of algae oil powder; puffed rice flour 70Kg (composition of example 3);
(2) dividing the puffed rice flour into three parts A, B and C according to the mass, wherein the mass of the part A is 15Kg as that of the yam micromolecule peptide; the mass of the part B is 5Kg as that of the lentinan, and the mass of the part C is 50Kg after subtracting the sum of the mass of the part A and the mass of the part B from the mass of the puffed rice flour in the step (1);
(3) airflow mixing the yam small molecular peptide and the part A of puffed rice flour for 25min to obtain a mixture I; airflow mixing Lentinus edodes glycopeptide and part B puffed rice flour for 25min to obtain mixture II; and (3) mixing the algae oil powder and the C part puffed rice flour for 15min in an air flow manner to obtain a mixture III, adding the mixture I and the mixture II into the mixture III, continuing mixing for 30min in an air flow manner, and drying to obtain the composition for inducing tumor cell apoptosis.
And in the air flow mixing process, starting a stirring paddle, blowing air with the temperature of 30 ℃, the relative humidity of 90% and the air speed of 7m/s into the stirring paddle at the speed of 6r/s so as to boil the materials.
The drying is as follows: air with the temperature of 60 ℃ and the relative humidity of 30 percent is introduced for 10 minutes at the wind speed of 10 m/s.
Test example 1
Animal modeling, grouping and administration:
80 mice (SPF grade, female mice, 18-22g, 5-6 weeks) were randomly divided into model group, blank group (normal group), experimental group including lentinan peptide group, yam small molecule peptide group, algae oil powder group, example 4 group, example 5 group, example 6 group. 10/group, weighed and recorded. U14 cells (from Tokyo (Shanghai) Biotech Co., Ltd., source: Chinese medical academy of sciences) growing to logarithmic phase were inoculated subcutaneously to axilla of right forelimb5/mL)2mL, 1 time/d, 1g/Kg, 14d total administration by intragastric administration on the day after inoculation; the model group mice were administered 1ml/Kg of physiological saline by gastric gavage.
Weighing the mass 24h after the last administration, killing the mice by cervical dislocation, taking and weighing the tumor mass according to the following formula
Tumor inhibition rate,% (test group/model group tumor mass)
And respectively calculating the tumor inhibition rate. The processing adopts SPSS statistical software to process data for data
The mean value comparison among the groups adopts one-factor analysis of variance, and the difference with P less than 0.05 has statistical significance.
TABLE 1 Effect on the body weight and tumor weight of cervical carcinoma U14 tumor-bearing mice (n ═ 10)
| Test group Classification | Body weight, g before administration | Body weight, g after administration | Tumor mass, mg | Tumor inhibition rate% |
| Model set | 16.56±2.87 | / | 107±8.42 | / |
| Blank group | 23.43±2.56 | 23.43±2.56 | / | / |
| Lentinus edodes glycopeptide | 16.56±2.87 | 18.45±2.13 | 92.34±8.36* | 15 |
| Chinese yam small molecular peptide | 16.56±2.87 | 18.37±2.41 | 89.34±8.42* | 17 |
| Algae oil powder | 16.56±2.87 | 18.19±1.37 | 96.34±8.37* | 11 |
| Example 4 | 16.56±2.87 | 21.75±2.13* | 45.74±5.19** | 58 |
| Example 5 | 16.56±2.87 | 21.12±1.71* | 50.38±4.34** | 47 |
| Example 6 | 16.56±2.87 | 21.05±2.42* | 56.23±3.25** | 48 |
Note: p <0.05, P <0.01,
through the test example 1, it can be seen that the influence of the raw material group (lentinan, yam small molecular peptide and algae oil powder) and the example group (example 4, example 5 and example 6) on the tumor mass content of the cervical cancer U14 tumor-bearing mice is different, and the tumor mass can be reduced (P < 0.05).
The weight of the raw material group (lentinan, yam micromolecular peptide and algae oil powder) has no significant difference relative to the weight of the model group. The results show that the weight of the mice is not improved, the malnutrition of the mice cannot be improved, and the weight of the mice is increased after the administration of the example groups (example 4, example 5 and example 6), and the differences of the weight of the mice relative to the model group are significant (P < 0.05). It is demonstrated that the group of examples (example 4, example 5, and example 6) can increase the body weight after administration and improve the malnutrition of mice. The formula food of the invention is superior to a single raw material, and has the effects of promoting tissue regeneration, improving the malnutrition of tumor patients and increasing the weight.
Test example 2
Animal modeling, grouping and administration: 50 mice (SPF grade, female mice, average body weight 18-22g, 5-6 weeks) were randomly assigned to model group, blank group (normal group), example 4 group, example 5 group, example 6 group, 10/group. Model and example groups a suspension of U14 cells (5 × 10) grown to logarithmic growth phase was inoculated subcutaneously in the axilla of the right forelimb5mL)2mL (from tokyo (shanghai) biotechnology limited, source: chinese academy of medical sciences), the groups of the examples and the inoculation are administered by intragastric administration for 1 time/d and 1g/Kg for 14 d; the model group mice were administered 1ml/Kg of physiological saline by gastric gavage.
Removing eyeball and blood 24 hr after last administration; killing mice by cervical dislocation, taking spleen and thymus, taking blood, centrifuging blood, separating serum, and detecting INF-gamma, TNF-alpha and IL-12 content according to the operation steps in the kit specification. The processing adopts SPSS statistical software to process data for data
The mean value comparison among the groups adopts one-factor analysis of variance, and the difference with P less than 0.05 has statistical significance.
TABLE 2 Effect on the levels of INF-. gamma., TNF-. alpha., IL-2 in the sera of mice bearing tumors of cervical carcinoma U14 (n. 10)
Note: p <0.05, P <0.01,
as can be seen from the table 2, the groups in example 4 enhance the constitution of the mice, improve the blood indexes INF-gamma, TNF-alpha and IL-2 of the serum of the cervical cancer U14 tumor-bearing mice, and have a significant difference P of less than 0.05.
Example 5 groups of mice enhance the body constitution, improve the blood indexes TNF-alpha and IL-2 of the blood serum of the tumor-bearing mice with cervical cancer U14, and the difference is obvious, wherein P is less than 0.05.
Example 6 groups of mice enhanced constitution, the main action mechanism of the mice enhanced the blood indexes INF-gamma and IL-2 of the blood serum of the mice with the tumor of cervical cancer U14, and the difference is significant, and the P is less than 0.05.
Interleukin 2(IL-2) has a powerful regulating effect on the immune system. TNF-alpha is a factor contained in serum and capable of killing some tumor cells or making in vivo tumor tissue undergo the process of blood necrosis, INF-gamma interferon is a high-effective antiviral biological active substance, and is a lymph factor with extensive immunoregulation action.
The composition of the invention is prepared into oral preparations which are beneficial to use, such as powder, granules, capsules, tablets and the like, and is used as anti-cancer food for preventing and treating cancers.
Claims (9)
1. The composition capable of inducing tumor cell apoptosis is characterized by being prepared from the following components in percentage by mass:
10% -20% of yam small molecular peptide; 5% -10% of lentinan; 10% of algae oil powder and 60% -70% of puffed rice flour.
2. The composition according to claim 1, characterized by consisting of, in mass percent:
20% of yam small molecular peptide; 10% of lentinan; 10% of algae oil powder; 60 percent of puffed rice flour.
3. The composition as claimed in claim 1 or 2, wherein the yam small molecule peptide has a peptide mass content of 80% or more, and a peptide mass content of 75% or more with a relative molecular weight of less than 1000 Da.
4. The composition as claimed in claim 1 or 2, wherein the glycopeptide of Lentinus edodes has a peptide mass content of 80% or more and a peptide mass content of 60% or more with a relative molecular weight of 500 Da or less.
5. The composition according to claim 1 or 2, wherein the algal oil powder has a DHA content of 10% by mass or more.
6. Method for the preparation of a composition with induction of apoptosis of tumor cells according to any one of claims 1 to 5, characterized in that it comprises the following steps:
(1) weighing Chinese yam micromolecule peptide according to the mass percentage; lentinan; algae oil powder and puffed rice flour;
(2) dividing the puffed rice flour into a part A, a part B and a part C according to the mass, wherein the mass of the part A is the same as that of the yam micromolecule peptide; the mass of the part B is equal to that of the lentinan peptide, and the mass of the part C is the sum of the mass of the puffed rice flour minus the mass of the part A and the mass of the part B;
(3) airflow mixing the yam small molecular peptide and the part A of puffed rice flour for 15-25min to obtain a mixture I; airflow mixing Lentinus Edodes glycopeptide and part B of puffed rice flour for 15-25min to obtain mixture II; and (3) mixing the algae oil powder and the C part puffed rice flour for 5-15min in an air flow manner to obtain a mixture III, adding the mixture I and the mixture II into the mixture III, continuing to mix for 20-30min in an air flow manner, and drying to obtain the composition for inducing tumor cell apoptosis.
7. The method of claim 6, wherein the gas streams are mixed by: starting the stirring paddle, wherein the speed of the stirring paddle is 6r/s, and simultaneously blowing air with the temperature of 20-30 ℃, the relative humidity of 80-90% and the air speed of 7m/s to boil the materials.
8. The method according to claim 6, wherein the drying is: air with the temperature of 60 ℃ and the relative humidity of 20-30% is introduced for 5-10 minutes at the wind speed of 10 m/s.
9. Use of a composition according to any one of claims 1 to 5 for the preparation of an anticancer food product.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202111046046.3A CN113693242A (en) | 2021-09-07 | 2021-09-07 | Composition capable of inducing tumor cell apoptosis and preparation method and application thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202111046046.3A CN113693242A (en) | 2021-09-07 | 2021-09-07 | Composition capable of inducing tumor cell apoptosis and preparation method and application thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN113693242A true CN113693242A (en) | 2021-11-26 |
Family
ID=78659041
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202111046046.3A Pending CN113693242A (en) | 2021-09-07 | 2021-09-07 | Composition capable of inducing tumor cell apoptosis and preparation method and application thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN113693242A (en) |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101258931A (en) * | 2007-03-08 | 2008-09-10 | 张清明 | Polypeptide health care vermicelli and instant noodles series products and preparation thereof |
| CN112725399A (en) * | 2020-12-29 | 2021-04-30 | 海南云皓生物科技有限公司 | Preparation method and application of lentinus edodes oligopeptide |
-
2021
- 2021-09-07 CN CN202111046046.3A patent/CN113693242A/en active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101258931A (en) * | 2007-03-08 | 2008-09-10 | 张清明 | Polypeptide health care vermicelli and instant noodles series products and preparation thereof |
| CN112725399A (en) * | 2020-12-29 | 2021-04-30 | 海南云皓生物科技有限公司 | Preparation method and application of lentinus edodes oligopeptide |
Non-Patent Citations (2)
| Title |
|---|
| 耿丽晶: "海洋多不饱和脂肪酸DHA抑制肿瘤机制的研究进展" * |
| 董怀灿，李敏: "怀山药肽的开发及应用" * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103478699B (en) | Edible fungus granular chewable tablets and preparation method thereof | |
| CN101721435B (en) | Ganoderma lucidum spore and nano selenium compound and preparation method thereof | |
| CN104543596A (en) | Special composite vitamin premix feed preparation for breeding poultry as well as preparation method and application thereof | |
| CN105999231B (en) | Polypeptide composition, composition for improving livestock and poultry immunity and preparation method | |
| CN104543534A (en) | Selenium-enriched quail egg feed additive and preparation method thereof | |
| KR101139372B1 (en) | Method for preparing feed additive and feed additivethere from | |
| CN101721433B (en) | Double-mushroom polysaccharide preparation containing flammulina velutipes polysaccharide and lentinan polysaccharide and preparation method and application thereof | |
| CN103083510A (en) | Chinese medicinal oral liquid for improving poultry immune function and its preparation method | |
| CN113693242A (en) | Composition capable of inducing tumor cell apoptosis and preparation method and application thereof | |
| WO2024082677A1 (en) | Hypoallergenic milk having immunity improving function and preparation method therefor | |
| CN112293604A (en) | Chinese herbal medicine additive for feeding laying hens and feeding method thereof | |
| CN105125606B (en) | Improve the chewable tablets and preparation method thereof of immunity | |
| CN101703155B (en) | Preparation method and application of prawn non-specific immunity reinforcing agent oligopeptide | |
| Park et al. | Hematopoietic effect of deer antler extract fermented by Bacillus subtilis on murine marrow cells | |
| CN109172803A (en) | A kind of hydrogen-rich Chinese medicine composition for relieving the effect of alcohol, food, health food, hydrogen-rich drunk-sobering tablet and preparation method thereof | |
| CN109497470A (en) | A kind of chlorella pyrenoidosa polypeptide alleviates getting fat composition and preparation method thereof | |
| CN112915110B (en) | Slimming and beautifying probiotic preparation and preparation method and application thereof | |
| CN111616357B (en) | GABA spleen-tonifying and nerve-soothing composition based on homology of medicine and food, preparation and application thereof | |
| JPH11152230A (en) | Composition containing mushroom or its extract | |
| CN108323762B (en) | Selenium-rich composition and preparation, preparation method and application thereof | |
| CN111493221A (en) | Traditional Chinese medicine feed additive for improving animal immunity and preparation method thereof | |
| JP4245291B2 (en) | Bioactive composition and method for producing the same | |
| CN108450958B (en) | Selenium-rich composition and application of preparation | |
| JPH0881371A (en) | Hematopoietic function promoter | |
| CN115918907B (en) | Endogenous hydrogen dietary nutritional supplements |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20211126 |